Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza in Type 2 Diabetes
IRCT20150303021315N15Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by CinnaGen. Started Jun 2019; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20150303021315N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150303021315N15.